Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00043329 · ClinicalTrials.gov registry record
Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis
A clinical trial of Osteopetrosis, sponsored by InterMune.
- Completed
- Registry status
- 6
- Enrollment target
- 1
- Study location
NCT00043329: Completed study of Osteopetrosis, sponsored by InterMune.
NCT00043329 is a study of Osteopetrosis that has completed, run by InterMune. The registered enrollment target is 6 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00043329, a study of Osteopetrosis, has completed, sponsored by InterMune.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to establish a registry of all children with severe, malignant osteopetrosis who are treated with Actimmune (IFN-g 1b or Interferon gamma-1b) to monitor the effects of IFN-g 1b on preventing progression of this disease and to follow the safety of patients receiving it on a long-term basis. In addition, evaluation of the possible effect of Actimmune therapy on the humoral response to normal childhood vaccinations in this same patient population will be examined.Interferon gamma is a substance that the body makes naturally.
Conditions Studied
Interventions
- DRUG Actimmune Registry
Study Locations (1)
California
- InterMune, Inc. - Brisbane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2002-01 |
| Est. Completion | 2005-09 |
What the finished NCT00043329 record still lists
NCT00043329 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 1 condition, with Osteopetrosis appearing as the primary indexed condition, and to 1 intervention - of which Actimmune Registry is the first listed.
NCT00043329 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00043329 about?
NCT00043329 is a clinical study titled "Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis". The purpose of this study is to establish a registry of all children with severe, malignant osteopetrosis who are treated with Actimmune (IFN-g 1b or Interferon gamma-1b) to monitor the effects of IFN-g 1b on preventing progression of this disease and to follow the safety of patients receiving it on...
What is the current status of trial NCT00043329?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2002-01. Estimated completion is 2005-09.
What conditions does trial NCT00043329 study?
This clinical trial studies the following conditions: Osteopetrosis.
What interventions are being tested in trial NCT00043329?
The interventions under investigation include: Actimmune Registry (DRUG).
Who is sponsoring clinical trial NCT00043329?
This trial is sponsored by InterMune, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00043329 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteopetrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia